Medicine: A new ally against cancer

Scientific American

Volumn 305, Issue 4, 2011, Pages 66-71

  Von Hofe, Eric ^a  

^a Antigen Express   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE;

ADOPTIVE IMMUNOTHERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; HISTORY; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; METHODOLOGY; NATIONAL HEALTH ORGANIZATION; NEOPLASM; UNITED STATES;

CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DRUG APPROVAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNOTHERAPY; IMMUNOTHERAPY, ADOPTIVE; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 80053409994     PISSN: 00368733     EISSN: None     Source Type: Journal    
DOI: 10.1038/scientificamerican1011-66     Document Type: Article

References (3)

1. A Malignant Flame. Gary Stix in Scientific American, Vol. 297, No. 1, pages 60-67; July 2007.
2. Strategies for Cancer Vaccine Development. Matteo Vergati et al. in Journal of Biomedicine and Biotechnology, Vol. 2010. Published online 2010. www.hindawi.com/journals/jbb/2010/596432
3. A New Era in Anticancer Peptide Vaccines. Sonia Perez et al. in Cancer, Vol. 116, No. 9, pages 2071-2080; May 1, 2010. www.ncbi.nlm.nih.gov/pubmed/ 20187092